Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK
- PMID: 16371790
- DOI: 10.1097/01.ico.0000179931.05275.dd
Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK
Abstract
Purpose: To report a case of corneal ulceration and perforation after PRK connected with high doses of ketorolac tromethamine (Acula).
Methods: A 31-year-old man presented 5 days after PRK in the left eye with corneal ulceration and perforation requiring penetrating keratoplasty. The patient admitted to using Acular every hour, ciprofloxocin every hour, and prednisolone acetate 1% QID postoperatively.
Results: Laboratory tests, including corneal cultures, were normal. A diagnosis of corneal ulceration secondary to incorrect use of high-dose ketorolac tromethamine was made.
Conclusion: Judicious patient counseling is recommended when using topical NSAIDs in the setting of PRK.
Comment in
-
Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugs.Cornea. 2006 Dec;25(10):1265-6. doi: 10.1097/01.ico.0000240100.92055.89. Cornea. 2006. PMID: 17172917 No abstract available.
-
Corneal ulceration and perforation with ketorolac tromethamine.Cornea. 2006 Dec;25(10):1268. doi: 10.1097/01.ico.0000229983.30957.a2. Cornea. 2006. PMID: 17172920 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources